141 related articles for article (PubMed ID: 11996324)
21. Determination of chlorpheniramine maleate and tincture ipecac in dosage form by liquid chromatography with ultraviolet detection.
Eldawy MA; Mabrouk MM; El-Barbary FA
J AOAC Int; 2003; 86(4):675-80. PubMed ID: 14509423
[TBL] [Abstract][Full Text] [Related]
22. Species differences in the biotransformation of an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist: the effects of distinct glucuronide metabolites on overall compound disposition.
Shaffer CL; Gunduz M; Ryder TF; O'Connell TN
Drug Metab Dispos; 2010 Feb; 38(2):292-301. PubMed ID: 19910512
[TBL] [Abstract][Full Text] [Related]
23. Selective, stability-indicating assay of the major ipecacuanha alkaloids, emetine and cephaeline, in pharmaceutical preparations by high-performance liquid chromatography using spectrofluorimetric detection.
Elvidge DA; Johnson GW; Harrison JR
J Chromatogr; 1989 Jan; 463(1):107-18. PubMed ID: 2715231
[TBL] [Abstract][Full Text] [Related]
24. [The purity test for cephaeline in emetine chloride, Ph. Dan. 1948].
MORCH J
Dan Tidsskr Farm; 1957 Apr; 31(4):73-9. PubMed ID: 13437707
[No Abstract] [Full Text] [Related]
25. Cephaeline promotes ferroptosis by targeting NRF2 to exert anti-lung cancer efficacy.
Chen P; Ye Q; Liang S; Zeng L
Pharm Biol; 2024 Dec; 62(1):195-206. PubMed ID: 38339810
[TBL] [Abstract][Full Text] [Related]
26. Ipecac syrup abuse, morbidity, and mortality: isn't it time to repeal its over-the-counter status?
Silber TJ
J Adolesc Health; 2005 Sep; 37(3):256-60. PubMed ID: 16109351
[TBL] [Abstract][Full Text] [Related]
27. [Colorimetric method for the determination of emetine and cephaeline in Cephaelis roots and in galenicals obtained from them].
WISNIEWSKI W; PIETURA A
Acta Pol Pharm; 1963; 20():43-51. PubMed ID: 14001348
[No Abstract] [Full Text] [Related]
28. Isolation and identification of the new metabolites of 1-[bis(4-fluorophenyl)-methyl]-4-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride (KB-2796) from rat bile, urine and feces.
Kawashima T; Satomi O; Awata N
J Pharmacobiodyn; 1991 Aug; 14(8):449-59. PubMed ID: 1774621
[TBL] [Abstract][Full Text] [Related]
29. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH
Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948
[TBL] [Abstract][Full Text] [Related]
30. Urinary and biliary metabolites of mephentermine in male Wistar rats.
Mori M; Uy N; Sakai K; Inoue M; Miyahara T; Kozuka H
Xenobiotica; 1989 Mar; 19(3):287-99. PubMed ID: 2665325
[TBL] [Abstract][Full Text] [Related]
31. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
[TBL] [Abstract][Full Text] [Related]
32. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
Prakash C; Soliman V
Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
[TBL] [Abstract][Full Text] [Related]
33. Death due to chronic syrup of ipecac use in a patient with bulimia.
Schiff RJ; Wurzel CL; Brunson SC; Kasloff I; Nussbaum MP; Frank SD
Pediatrics; 1986 Sep; 78(3):412-6. PubMed ID: 2875430
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and metabolism of an alpha,beta-blocker, amosulalol hydrochloride, in mice: biliary excretion of carbamoyl glucuronide.
Suzuki K; Kamimura H
Biol Pharm Bull; 2007 Aug; 30(8):1580-5. PubMed ID: 17666826
[TBL] [Abstract][Full Text] [Related]
35. Metabolism and excretion of kakkalide and its metabolites in rat urine, bile, and feces as determined by HPLC/UV and LC/MS/MS.
Wang H; Bai X; Sun J; Kano Y; Makino T; Yuan D
Planta Med; 2013 Nov; 79(16):1552-7. PubMed ID: 24108437
[TBL] [Abstract][Full Text] [Related]
36. Ipecac toxicity in "Munchausen syndrome by proxy".
Bader AA; Kerzner B
Ther Drug Monit; 1999 Apr; 21(2):259-60. PubMed ID: 10217350
[TBL] [Abstract][Full Text] [Related]
37. Metabolism of 2- and 3-tert-butyl-4-hydroxyanisole in the rat (III): Metabolites in the urine and feces.
Hirose M; Hagiwara A; Inoue K; Ito N; Kaneko H; Saito K; Matsunaga H; Isobe N; Yoshitake A; Miyamoto J
Toxicology; 1988 Dec; 53(1):33-43. PubMed ID: 3201475
[TBL] [Abstract][Full Text] [Related]
38. Characterization of metabolites of benz(j)aceanthrylene in faeces, urine and bile from rat.
Hegstad S; Lundanes E; Holme JA; Alexander J
Xenobiotica; 1999 Dec; 29(12):1257-72. PubMed ID: 10647911
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics, metabolism, and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in rats and rhesus monkeys.
Tan EY; Hartmann G; Chen Q; Pereira A; Bradley S; Doss G; Zhang AS; Ho JZ; Braun MP; Dean DC; Tang W; Kumar S
Drug Metab Dispos; 2010 Mar; 38(3):459-73. PubMed ID: 20016052
[TBL] [Abstract][Full Text] [Related]
40. Quantitative analysis of emetine and cephaeline by reversed-phase high performance liquid chromatography with fluorescence detection.
Crouch DJ; Moran DM; Finkle BS; Peat MA
J Anal Toxicol; 1984; 8(2):63-5. PubMed ID: 6716976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
